Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a listen. Also, Moderna’s RSV vaccine efficacy seems lackluster compared to competitors, and the Bernie Sanders drug pricing song-and-dance did not seem to faze pharma CEOs.
The need-to-know this morning:
- Metagenomi, a gene editing startup, raised $94 million in an initial public offering.
Has AI really solved biology?
What can machines teach us about medicine? And what’s a digital twin? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect